Institutional review boards (IRBs) review clinical studies and approve those that meet regulatory criteria and ethical guidelines. The review process considers various factors, such as whether the generalizable knowledge likely to be generated by the study justifies the risks of harm imposed on study participants. Because clinical studies are experiments, there are many unknowns. In all but the most trivial cases, IRBs must, therefore, deal with uncertainty.
展开▼
